APA (7th ed.) Citation

Koren, E., Yaacov, A., Zidan, J., C. Roisman, L., Peled, N., & Asna, N. (2026). Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study. Journal of Clinical Medicine, 15(12), 4757. https://doi.org/10.3390/jcm15124757

Chicago Style (17th ed.) Citation

Koren, Einav, Adar Yaacov, Jamal Zidan, Laila C. Roisman, Nir Peled, and Noam Asna. "Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study." Journal of Clinical Medicine 15, no. 12 (2026): 4757. https://doi.org/10.3390/jcm15124757.

MLA (9th ed.) Citation

Koren, Einav, et al. "Real-World Outcomes of First-Line Pembrolizumab-Based Therapy in Advanced Non-Small-Cell Lung Cancer: A Retrospective Single-Center Study." Journal of Clinical Medicine, vol. 15, no. 12, 2026, p. 4757, https://doi.org/10.3390/jcm15124757.